POM to P switches: what made Maloff Protect and ellaOne a success?
C+D deputy editor Grace Lewis spoke to Anna Maxwell, CEO of medicines switching company Maxwellia, about what makes a successful POM to P change
Ms Maxwell has analysed over 30 medicine reclassifications, from prescription-only medicine (POM) to one available to purchase in pharmacies (P), she tells C+D. From ellaOne to Maloff Protect, she knows what makes a successful change.
In this podcast, she speculates on what other switches might be coming down the line, “beyond the cough, cold, pain and gastro categories”. She also explains why pharmacy teams should “embrace” medicine switches to encourage more investment in the sector.
You can listen to the podcast below. Alternatively, subscribe to C+D's podcasts on iTunes or by searching 'Chemist+Druggist podcast' on your preferred android podcast app.